The straight answer
This is the rare case where the honest answer is yes. Several of the most effective obesity treatments ever made are peptides, and a few of them are FDA-approved and sitting in this library. The GLP-1 medicines you've heard about - semaglutide (Wegovy) and tirzepatide (Zepbound) - are peptide drugs, and large human trials show real, lasting weight loss of roughly 15% to 20% of body weight. The catch: the ones that work are prescription medicines that need a doctor, not the 'research chemical' fat-loss peptides sold online, most of which have never been proven to do anything in a person.
What actually treats it
Care starts with sustained changes to eating, activity, and sleep, and for many people now includes a prescription GLP-1 medicine (semaglutide, tirzepatide, or liraglutide) taken long-term under a doctor's supervision. For severe obesity, metabolic (bariatric) surgery remains the most powerful and durable option - a real doctor should help you weigh which path fits your health.
From our library
Compounds here with any tie to obesity — rated honestly for this specific use.
- Proven
Tirzepatide
Worth a lookFDA-approved for weight loss as Zepbound and the strongest obesity drug available today - large human trials showed around 20% body weight loss over 72 weeks. It's a real prescription medicine with real GI side effects, not something to source or dose on your own.
- Proven
Semaglutide
Worth a lookFDA-approved for weight loss as Wegovy, with roughly 15% average body weight loss in large trials plus heart-risk benefits. Proven and widely used - but a prescription drug that needs medical supervision for dosing and side effects.
- Proven
Liraglutide
Worth a lookFDA-approved for weight loss as Saxenda, backed by large trials. It works but is a daily injection and has been largely eclipsed by the newer once-weekly drugs that lose more weight with less hassle.
- Emerging
Retatrutide
Worth a lookAn experimental triple-hormone injection that produced the biggest weight loss ever recorded for a drug in this class in real human trials. Not yet approved anywhere and long-term safety data is still coming in - a future option, not a current one.
- Emerging
Cagrilintide
Worth a lookCopies the 'I'm full' hormone amylin; on its own and especially paired with semaglutide (CagriSema) it drove around 20% weight loss in large human trials. Still investigational - promising but not yet an approved medicine.
- Emerging
Survodutide
Worth a lookAn experimental dual-hormone weekly injection that produced major weight loss and less liver fat in large human trials. Real evidence, but not yet approved by any regulator.
- Emerging
Mazdutide
Worth a lookA dual-hormone weekly injection with strong human trial results for weight loss; approved in China but not in the US or Europe. Promising and further along than most, but not yet available or approved where most readers live.
- Emerging
Orforglipron
Worth a lookA once-daily GLP-1 pill (no needle) in late-stage human trials for weight loss. Could be a big deal if approved, but it's still investigational - not yet a prescription you can get.
- Moderate
Exenatide
Worth a lookAn approved GLP-1 medicine for type 2 diabetes that also causes modest weight loss. Real and proven, but its weight effect is smaller than the newer GLP-1 drugs, so it's rarely the first choice for obesity itself.
- Moderate
Dulaglutide
Worth a lookAn approved once-weekly GLP-1 diabetes medicine (Trulicity) that gives modest weight loss as a side benefit. Proven and safe under a doctor's care, but not as strong for weight as semaglutide or tirzepatide.
- Early
Tesofensine
SpeculativeAn experimental weight-loss pill that produced some of the largest results ever seen in obesity trials - but it was never approved, raises heart rate and blood pressure, and works differently (a brain stimulant-type drug, not a gut hormone). Real human data exists, but the safety questions are why it stalled.
- Moderate
Tesamorelin
SpeculativeFDA-approved, but only to shrink deep belly fat in people with HIV-related fat redistribution - not for general obesity. It's proven for that narrow use; there's no good evidence it's a weight-loss drug for the general population.
- Early
AOD-9604
Not reallyA growth-hormone fragment that was actually tested as an obesity drug in humans - and failed to beat placebo, so it was never approved. It's now sold online as an unregulated research chemical with no proven fat-loss benefit.
- Early
5-Amino-1MQ
SpeculativeBlocks a metabolism enzyme and showed fat loss in mice and lab dishes, which is why it's marketed for weight loss. But it has never been tested in a single human trial - the fat-loss story is entirely animal data.
- Early
Adipotide
Not reallyDesigned to starve fat tissue by destroying its blood supply; it caused weight loss in monkeys and mice but was never tested in people, and raised kidney safety concerns. Not a viable or safe human treatment.
Also being studied (not in our library)
- Setmelanotide (Imcivree) — An FDA-approved MC4R peptide - but only for rare genetic and hypothalamic causes of obesity (like Bardet-Biedl syndrome or POMC/leptin-receptor deficiency). If your obesity runs in extreme, early-onset patterns in your family, ask a doctor whether genetic testing and this drug apply to you.
- Amycretin — A next-generation experimental peptide (GLP-1 plus amylin) in early human trials that has shown very large weight loss. Not approved yet, but one of the most closely watched drugs in the pipeline.
Bottom line
Obesity is the one condition where peptides genuinely deliver - the GLP-1 medicines in this library are among the most effective treatments we have, with real human proof behind them. The line that matters is prescription versus 'research chemical': the approved peptides work and belong in a doctor's hands, while most fat-loss peptides sold online do not.